Loading insider details...
Beta
Latest Form 4 (Mar 31, 2026): Grant/Award of 65,000 ATOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 31, 2026 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 65,000 | n/a |
| Jan 22, 2026 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 325,203 | n/a |
| May 22, 2025 | ATOSSA THERAPEUTICS, INC. (ATOS) | Purchase | 11,239 | $9.9K |
| May 16, 2025 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,366,062 | n/a |
| Jul 1, 2024 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,795,100 | n/a |
| Mar 6, 2023 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,873,100 | n/a |
| Feb 28, 2022 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,900,000 | n/a |
| May 18, 2021 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,900,000 | n/a |
| May 18, 2021 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 1,900,000 | n/a |
| Apr 13, 2020 | ATOSSA THERAPEUTICS, INC. (ATOS) | Grant/Award | 195,000 | n/a |